SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 36 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,513,451 | -75.3% | 4,500,000 | -75.8% | 0.00% | -100.0% |
Q4 2022 | $18,285,228 | +101.1% | 18,600,000 | +100.0% | 0.00% | 0.0% |
Q3 2022 | $9,092,000 | +7.2% | 9,300,000 | +6.3% | 0.00% | 0.0% |
Q2 2022 | $8,481,000 | -12.0% | 8,750,000 | -11.2% | 0.00% | – |
Q1 2022 | $9,636,000 | -11.7% | 9,850,000 | -10.5% | 0.00% | -100.0% |
Q4 2021 | $10,909,000 | +11.8% | 11,000,000 | +11.1% | 0.00% | 0.0% |
Q3 2021 | $9,754,000 | -5.0% | 9,900,000 | -4.8% | 0.00% | 0.0% |
Q2 2021 | $10,266,000 | -6.1% | 10,400,000 | -8.0% | 0.00% | 0.0% |
Q1 2021 | $10,934,000 | +30.8% | 11,300,000 | +27.7% | 0.00% | 0.0% |
Q4 2020 | $8,358,000 | +2.0% | 8,850,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $8,195,000 | -6.2% | 8,850,000 | -10.6% | 0.00% | 0.0% |
Q2 2020 | $8,740,000 | -9.8% | 9,900,000 | -16.8% | 0.00% | 0.0% |
Q1 2020 | $9,689,000 | -8.1% | 11,900,000 | +2.4% | 0.00% | 0.0% |
Q4 2019 | $10,548,000 | -2.7% | 11,625,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $10,837,000 | -3.9% | 11,625,000 | +0.9% | 0.00% | 0.0% |
Q2 2019 | $11,276,000 | – | 11,525,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 45,402,000 | $44,828,000 | 4.21% |
Radcliffe Capital Management, L.P. | 69,010,000 | $67,802,000 | 1.97% |
Penn Mutual Asset Management | 675 | $672,000 | 1.06% |
CAMDEN ASSET MANAGEMENT L P /CA | 24,548,000 | $24,118,000 | 0.95% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 38,428,000 | $38,079,000 | 0.87% |
DeepCurrents Investment Group LLC | 21,155,000 | $20,805,000 | 0.62% |
SHENKMAN CAPITAL MANAGEMENT INC | 6,813,000 | $6,618,000 | 0.51% |
OAKTREE CAPITAL MANAGEMENT LP | 22,348,000 | $22,068,000 | 0.31% |
WOLVERINE ASSET MANAGEMENT LLC | 16,540,000 | $16,325,000 | 0.14% |
AVIVA PLC | 17,300,000 | $16,926,000 | 0.08% |